Kailera Therapeutics, Inc. (KLRA) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading KLRA…

Kailera Therapeutics, Inc. (KLRA) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

Kailera Therapeutics, Inc.

KLRA · CIK 2096997

4 · Sep 9, 2026 · Chief Technology Officer Nicholson Nur was granted 220K Stock Option (right to buy)

4

Chief Technology Officer Nicholson Nur was granted 220K Stock Option (right to buy)

Filed: Sep 9, 2026
Period: Sep 7, 2026
Accession: 0001193125-26-386782
Filer: Kailera Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov